Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer
NCT01832948Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jan 2013
- Primary completion
- Jan 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in metastatic colorectal cancer (mCRC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01832948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01832948.